SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases
Author:
Publisher
Elsevier BV
Subject
Nephrology,Internal Medicine
Reference24 articles.
1. The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection;Brown;Ann Med,2021
2. Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials;Tang;Diabetologia,2016
3. Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: a post hoc analysis of 10 randomized, placebo-controlled trials;Toto;J Diabetes Complications,2019
4. Comparative effects of sodium-glucose cotransporter 2 inhibitors on serum electrolyte levels in patients with type 2 diabetes: a pairwise and network meta-analysis of randomized controlled trials;Zhang;Kidney360,2022
5. SGLT2 inhibitors for treatment of refractory hypomagnesemia: a case report of 3 patients;Ray;Kidney Med,2020
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Glucagon in the Effects of SGLT2 Inhibition on Potassium and Magnesium Homeostasis;KIDNEY MED;2024
2. Role of Glucagon in the Effects of SGLT2 Inhibition on Potassium and Magnesium Homeostasis;Kidney Medicine;2024-09
3. Magnesium biology;Nephrology Dialysis Transplantation;2024-06-13
4. Magnesium Disorders;New England Journal of Medicine;2024-06-06
5. The Role of Sodium-Glucose Co-transporter 2 Inhibitors in Patients With Hypomagnesemia: A Systematic Review;Cureus;2024-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3